[1]李托弟,周姝雯,徐 昆.某院2018-2022年病理科恶性肿瘤患者病例特征分析[J].医学信息,2024,37(05):63-67.[doi:10.3969/j.issn.1006-1959.2024.05.010]
　LI Tuo-di,ZHOU Shu-wen,XU Kun.Analysis of Case Characteristics of Malignant Tumor Patients in Pathology Department of a Hospital from 2018 to 2022[J].Journal of Medical Information,2024,37(05):63-67.[doi:10.3969/j.issn.1006-1959.2024.05.010]
点击复制

某院2018-2022年病理科恶性肿瘤患者病例特征分析()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
37卷
期数:
2024年05期
页码:
63-67
栏目:
公共卫生信息学
出版日期:
2024-03-01

文章信息/Info

Title:
Analysis of Case Characteristics of Malignant Tumor Patients in Pathology Department of a Hospital from 2018 to 2022
文章编号:
1006-1959（2024）05-0063-05
作者:
李托弟; 周姝雯; 徐 昆
（1.黔西南布依族苗族自治州人民医院病理科，贵州 兴义 562400；2.兰州大学基础医学院免疫研究所，甘肃 兰州 730000）
Author(s):
LI Tuo-di; ZHOU Shu-wen; XU Kun
(1.Department of Pathology,People’s Hospital of Qianxinan Buyi and Miao Minority Autonomous Prefecture,Xingyi 562400,Guizhou,China;2.Institute of Immunology,School of Basic Medicine,Lanzhou University,Lanzhou 730000,Gansu,China)
关键词:
恶性肿瘤; 患者; 病例特征; 防治; 普查
Keywords:
Malignanttumor; Patient; Casecharacteristics; Prevention and cure; General survey
分类号:
R73-31；R197.323
DOI:
10.3969/j.issn.1006-1959.2024.05.010
文献标志码:
A
摘要:
目的 分析某院恶性肿瘤患者的构成及分布情况，为该地区开展恶性肿瘤预防和治疗工作提供参考数据。方法 收集黔西南州人民医院2018-2022年恶性肿瘤病例。统计该院肿瘤患者性别、年龄、癌种等的分布情况。结果 某院2018-2022年经病理确诊恶性肿瘤病例共3935例，其中男性1942例，女性1993例，男女比例为0.976∶1。恶性肿瘤患者主要集中在36岁以上人群，共计3703人（94.10%）。2018-2021年恶性肿瘤患者数量逐年递增，2022年稍有下降，排名前5的病种为肺癌、肠癌、宫颈癌、头颈部恶性肿瘤、乳腺癌。男性排名前5的病种为肺癌、肠癌、头颈部恶性肿瘤、胃癌、膀胱癌。女性排名前5的病种为宫颈癌、肠癌、乳腺癌、头颈部恶性肿瘤、肺癌。36岁以上男性肺癌与肠癌患者总和占男性恶性肿瘤患者人数的56.08%；36岁以上女性肠癌、宫颈癌、乳腺癌及甲状腺癌占女性恶性肿瘤患者人数的67.59%。男性肺癌多表现为鳞状细胞癌，女性多表现为腺癌。头颈部恶性肿瘤中，以女性甲状腺癌占比最多。结论 应根据年龄与性别差异将各高发的恶性肿瘤纳入普查范围，并进一步加强学科研究，优化相应的医疗资源配置，针对恶性肿瘤的防治配合有关部门制定相应的措施，在一定程度上降低该地区恶性肿瘤的发生率，并为恶性肿瘤患者争取更长的有效救治时间。
Abstract:
Objective To analyze the composition and distribution of patients with malignant tumors in a hospital, and to provide reference data for the prevention and treatment of malignant tumors in the region.Methods Malignant tumor cases in People’s Hospital of Qianxinan Buyi and Miao Minority Autonomous Prefecture from 2018 to 2022 were collected. The distribution of gender, age and cancer types of tumor patients in the hospital was statistically analyzed.Results A total of 3935 cases of malignant tumors were diagnosed by pathology in a hospital from 2018 to 2022, including 1942 males and 1993 females, with a male to female ratio of 0.976∶1. Malignant tumor patients were mainly concentrated in the population over 36 years old, a total of 3703 people (94.10%). The number of patients with malignant tumors increased year by year from 2018 to 2021, and decreased slightly in 2022. The top five diseases were lung cancer, colorectal cancer, cervical cancer, head and neck malignant tumors, and breast cancer. The top 5 diseases in males were lung cancer, intestinal cancer, head and neck cancer, gastric cancer and bladder cancer. The top 5 diseases in women were cervical cancer, colorectal cancer, breast cancer, head and neck cancer and lung cancer. The total number of male patients with lung cancer and colorectal cancer over 36 years old accounted for 56.08% of male patients with malignant tumors. Women over 36 years old with colorectal cancer, cervical cancer, breast cancer and thyroid cancer accounted for 67.59% of the number of female patients with malignant tumors. Male lung cancer was mostly squamous cell carcinoma, and female lung cancer was mostly adenocarcinoma. Among the head and neck malignant tumors, female thyroid cancer accounted for the most.Conclusion According to the age and gender differences, the high incidence of malignant tumors should be included in the scope of the census, and further strengthen the subject research, optimize the corresponding medical resource allocation, and formulate corresponding measures for the prevention and treatment of malignant tumors with the relevant departments, so as to reduce the incidence of malignant tumors in the region to a certain extent, and strive for a longer effective treatment time for patients with malignant tumors.

参考文献/References:

[1]Kocarnik JM,Compton K,Dean FE,et al.Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019: A Systematic Analysis for the Global Burden of Disease Study 2019 [J].JAMA Oncol,2022,8(3):420-444.[2]Sung H,Ferlay J,Siegel RL,et al.Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries [J].CA Cancer J Clin,2021,71(3):209-249.[3]宋蓉.山东省某三级甲等中医医院恶性肿瘤住院病例分析[J].中国医院统计,2022,29(4):283-286.[4]Hassan C,Spadaccini M,Iannone A,et al.Performance of artificial intelligence in colonoscopy for adenoma and polyp detection: a systematic review and meta-analysis [J].Gastrointest Endosc,2021,93(1):77-85.e76.[5]Togawa K,Leon ME,Lebailly P,et al.Cancer incidence in agricultural workers: Findings from an international consortium of agricultural cohort studies (AGRICOH) [J].Environ Int,2021,157:106825.[6]Chiodi I,Mondello C.Life style factors, tumor cell plasticity and cancer stem cells [J].Mutat Res Rev Mutat Res,2020,784:108308.[7]吕志窕,吕志良,胡慧群.2009-2018年永康市某医院恶性肿瘤住院病例回顾性分析[J].中国医院统计,2020,27(1):67-69.[8]Lemaire J,Larrue R,Perrais M,et al.[Fundamental aspects of oncogenesis] [J].Bull Cancer,2020,107(11):1148-1160.[9]孙可欣,郑荣寿,张思维,等.2015年中国分地区恶性肿瘤发病和死亡分析 [J].中国肿瘤,2019,28(1):1-11.[10]唐仁章,董华,刘韦淞,等.2015年海南省肿瘤登记地区不同民族恶性肿瘤发病分析[J].中华肿瘤防治杂志,2022,29(11):786-794.[11]Shetty V,Kundapur R,Chandramohan S,et al.Dietary Risk with Other Risk Factors of Breast Cancer [J].Indian J Community Med,2021,46(3):396-400.[12]Bray F,Ferlay J,Soerjomataram I,et al.Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries [J].CA Cancer J Clin,2018,68(6):394-424.[13]Mao Y,Yang D,He J,et al.Epidemiology of Lung Cancer[J].Surg Oncol Clin N Am,2016,25(3):439-445.[14]Hong S,Mok Y,Jeon C,et al.Tuberculosis, smoking and risk for lung cancer incidence and mortality [J].Int J Cancer,2016,139(11):2447-2455.[15]Govindan R,Ding L,Griffith M,et al.Genomic landscape of non-small cell lung cancer in smokers and never-smokers [J].Cell,2012,150(6):1121-1134.[16]Tolwin Y,Gillis R,Peled N.Gender and lung cancer-SEER-based analysis[J].Ann Epidemiol,2020,46:14-19.[17]陶雨香.吉林省某三甲医院甲状腺癌患者病例分析[D].长春:吉林大学,2018.[18]Zhang D,Tang J,Kong D,et al.Impact of Gender and Age on the Prognosis of Differentiated Thyroid Carcinoma: a Retrospective Analysis Based on SEER [J].Horm Cancer,2018,9(5):361-370.[19]Sugano K.Screening of gastric cancer in Asia [J].Best Pract Res Clin Gastroenterol,2015,29(6):895-905.[20]Suh M,Choi KS,Lee YY,et al.Cancer screening in Korea, 2012: results from the Korean National Cancer Screening Survey [J].Asian Pac J Cancer Prev,2013,14(11):6459-6463.

相似文献/References:

[1]袁东方,张刚刚.恶性肿瘤病历主要诊断选择思路分析[J].医学信息,2018,31(07):28.[doi:10.3969/j.issn.1006-1959.2018.07.010]
　YUAN Dong-fang,ZHANG Gang-gang.Analysis of Main Diagnostic Options for Malignant Tumor Records[J].Journal of Medical Information,2018,31(05):28.[doi:10.3969/j.issn.1006-1959.2018.07.010]
[2]陶碧君,刘建德,王玉洲.LncRNA FOXD3-AS1在恶性肿瘤中的表达、功能及作用机制[J].医学信息,2022,35(10):51.[doi:10.3969/j.issn.1006-1959.2022.10.012]
　TAO Bi-jun,LIU Jian-de,WANG Yu-zhou.Expression, Function and Mechanism of LncRNA FOXD3-AS1 in Malignant Tumors[J].Journal of Medical Information,2022,35(05):51.[doi:10.3969/j.issn.1006-1959.2022.10.012]
[3]张国锐,贾 林,赵 丹,等.老年维持血液透析患者恶性肿瘤发病的相关因素分析[J].医学信息,2022,35(10):113.[doi:10.3969/j.issn.1006-1959.2022.10.027]
　ZHANG Guo-rui,JIA Lin,ZHAO Dan,et al.Analysis of Related Factors of Malignant Tumor in Elderly Maintenance Hemodialysis Patients[J].Journal of Medical Information,2022,35(05):113.[doi:10.3969/j.issn.1006-1959.2022.10.027]
[4]姜天奇,张洪亮.原发性肝癌的中西医治疗现状[J].医学信息,2019,32(13):35.[doi:10.3969/j.issn.1006-1959.2019.13.012]
　JIANG Tian-qi,ZHANG Hong-liang.Current Status of Treatment of Primary Liver Cancer with Traditional Chinese Medicine and Western Medicine[J].Journal of Medical Information,2019,32(05):35.[doi:10.3969/j.issn.1006-1959.2019.13.012]
[5]何 静.上皮性卵巢癌化学治疗的研究[J].医学信息,2019,32(18):24.[doi:10.3969/j.issn.1006-1959.2019.18.009]
　HE Jing.Chemotherapy of Epithelial Ovarian Cancer[J].Journal of Medical Information,2019,32(05):24.[doi:10.3969/j.issn.1006-1959.2019.18.009]
[6]梁春玲,杨文珊.消化道恶性肿瘤的临床分析[J].医学信息,2019,32(18):124.[doi:10.3969/j.issn.1006-1959.2019.18.041]
　LIANG Chun-ling,YANG Wen-shan.Clinical Analysis of Malignant Tumors of the Digestive Tract[J].Journal of Medical Information,2019,32(05):124.[doi:10.3969/j.issn.1006-1959.2019.18.041]
[7]陈云娥,李 璠,张子怡,等.营养支持治疗对终末期恶性肿瘤患者临床结局影响的Meta分析[J].医学信息,2019,32(19):63.[doi:10.3969/j.issn.1006-1959.2019.19.019]
　CHEN Yun-e,LI Fan,ZHANG Zi-yi,et al.Meta-analysis of Effect of Nutritional Support Therapy on Clinical Outcome of Patients with Terminal-stage Malignant Tumor[J].Journal of Medical Information,2019,32(05):63.[doi:10.3969/j.issn.1006-1959.2019.19.019]
[8]杜鑫荣.超声造影在肝实质性肿块诊断及鉴别中的临床价值[J].医学信息,2019,32(19):176.[doi:10.3969/j.issn.1006-1959.2019.19.059]
　DU Xin-rong.Clinical Value of Contrast-enhanced Ultrasonography in the Diagnosis and Differential Diagnosis of Liver Mass[J].Journal of Medical Information,2019,32(05):176.[doi:10.3969/j.issn.1006-1959.2019.19.059]
[9]易亭伍,邓窈窕,宿向东.恶性肿瘤患者及家属信息需求现状的多中心研究[J].医学信息,2019,32(22):72.[doi:10.3969/j.issn.1006-1959.2019.22.023]
　YI Ting-wu,DENG Yao-tiao,SU Xiang-dong.Multi-center Study on the Status of Information Needs of Patients with Malignant Tumors and their Families[J].Journal of Medical Information,2019,32(05):72.[doi:10.3969/j.issn.1006-1959.2019.22.023]
[10]赵博志,赵国林,杨 敏,等.乳腺鳞状细胞癌的临床诊疗研究[J].医学信息,2020,33(03):46.[doi:10.3969/j.issn.1006-1959.2020.03.014]
　ZHAO Bo-zhi,ZHAO Guo-lin,YANG Min,et al.Clinical Diagnosis and Treatment of Squamous Cell Carcinoma of the Breast[J].Journal of Medical Information,2020,33(05):46.[doi:10.3969/j.issn.1006-1959.2020.03.014]

更新日期/Last Update: 1900-01-01